Drugs / LASW1510
last change Mar 2012 re-read 2 minutes ago

LASW1510

Developed for
actinic keratosis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01265602 Comparator Nov 2010 → Mar 2012 actinic keratosis Almirall, S.A. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LASW1510 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01265602